Press release
Rheumatoid Arthritis Drugs Market Expected to Achieve 2.3% CAGR by 2029: Growth Forecast Insights
Rheumatoid Arthritis Drugs
How Large Will the Rheumatoid Arthritis Drugs Market Size By 2025?
In recent years, there has been a slight increase in the size of the rheumatoid arthritis drugs market. The market is predicted to expand from $60.3 billion in 2024 to $60.71 billion in 2025, with a compound annual growth rate (CAGR) of 0.7%. The historical growth has been influenced by factors such as a rise in disease prevalence, developments in healthcare infrastructure, educational and awareness programs, governmental initiatives, and strategic collaborations.
How Big Is the Rheumatoid Arthritis Drugs Market Size Expected to Grow by 2029?
The market for rheumatoid arthritis medication is anticipated to consistently expand over the coming years, reaching a value of $66.61 billion in 2029 with a compound annual growth rate of 2.3%. This projected increase within the forecasting period is fueled by the trends in personalized medicine, emerging market expansion, advancements in pipeline development, focus on combination therapies, and an increase in spending on healthcare. Major trends that are expected to dominate within the forecast period include the influence of biological therapies, the impact of biosimilars, progress in personalized medicine, the growth of oral therapies, and an emphasis on early diagnosis and intervention.
View the full report here:
https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report
Which Key Market Drivers Powering Rheumatoid Arthritis Drugs Market Expansion and Growth?
The escalating incidence of arthritis is anticipated to boost further expansion of the rheumatoid arthritis drugs market. Rheumatoid arthritis is a form of autoimmune and inflammatory disease that causes the immune system to mistakenly attack healthy cells, resulting in inflammation (painful swelling) in impacted body parts. Numerous rheumatoid arthritis drugs and self-care methods are on hand to effectively manage this condition. These drugs are designed to alleviate pain, improve joint mobility, and halt disease progression. The National Center for Health Statistics, a US government agency, reported in 2024 that in 2022, the age-adjusted prevalence of arthritis diagnosis in adults stood at 18.9%, with women (21.5%) being more prone to it than men (16.1%). The prevalence notably rose with age, scaling from 3.6% in adults between 18-34 years to a staggering 53.9% in individuals aged 75 and older. As such, the rising instances of arthritis are set to drive the growth of the rheumatoid arthritis drugs market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10120&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Rheumatoid Arthritis Drugs Market?
The trend of product innovations is catching on in the rheumatoid arthritis drug market. Businesses involved in the creation of drugs for rheumatoid arthritis are consistently launching new products to maintain their market presence. For example, R-Pharm, a private high-tech pharmaceutical firm from Russia, introduced Olokizumab in August 2022. This is a humanized monoclonal antibody that targets the interleukin-6 cytokine, a messenger molecule involved in the progression of rheumatoid arthritis joint destruction. This molecule, like TNF (tumor necrosis factor), initiates inflammatory responses in the body, which helps to reduce the disease activity in numerous rheumatoid arthritis patients.
What Are the Emerging Segments in the Rheumatoid Arthritis Drugs Market?
The rheumatoid arthritis drugs market covered in this report is segmented -
1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Response Modifiers (BRMs), Other Drug Types
2) By Route Of Administration: Oral, Parenteral, Topical, Other Route Of Administrations
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Indomethacin
2) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone
3) By Disease-Modifying Antirheumatic Drugs: Methotrexate, Sulfasalazine, Hydroxychloroquine, Leflunomide
4) By Biologic Response Modifiers: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, B-cell Inhibitors
5) By Other Drug Types: Janus Kinase Inhibitors, Other Novel Therapies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10120&type=smp
Who Are the Global Leaders in the Rheumatoid Arthritis Drugs Market?
Major companies operating in the rheumatoid arthritis drugs market include Pfizer Inc., Abbvie Inc., Amgen Inc., Novartis AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, F-Hoffmann La Roche AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Merck & Co Inc., Johnson & Johnson Inc., Bayer AG, Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A, Biogen Inc., Regeneron Pharmaceuticals Inc., Galapagos NV, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, UCB S.A., Astellas Pharma Inc., Corbus Pharmaceuticals Holdings Inc., Roche Holding AG, Daiichi Sankyo Company Limited, Mallinckrodt Pharmaceuticals, Gilead Sciences Inc.
Which are the Top Profitable Regional Markets for the Rheumatoid Arthritis Drugs Industry?
North America was the largest region in the rheumatoid arthritis drugs market in 2024.North America is expected to be the fastest-growing region in the global rheumatoid arthritis market report during the forecast period. The regions covered in the rheumatoid arthritis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10120
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rheumatoid Arthritis Drugs Market Expected to Achieve 2.3% CAGR by 2029: Growth Forecast Insights here
News-ID: 4097301 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
